Mark. A Rettenmaier, MD
Mark A. Rettenmaier MD, FACOG, FACS attended Medical School at the University of Iowa. He completed an Internship and Residency in Gynecology and Obstetrics at the University of California, Davis. His Fellowship in Gynecologic Oncology was performed at the University of California, Irvine. He is currently a Clinical Asssociate Professor of Obstetrics and Gynecology at the University of California, Los Angeles and formerly an Assistant Professor of Gynecologic Oncology at the University of California, Irvine and the University of Nevada. He is a Fellow of the American College of Obstetrics and Gynecology and a Fellow of the American College of Surgeons.
Please read important information before downloading the forms
BUSINESS ADDRESS
Gynecologic Oncology Associates
351 Hospital Road
Suite 507
Newport Beach , California 92663
Phone: (949) 642-1361
Fax: (949) 642-1394
mretten@cox.net
PERSONAL INFORMATION
Date of Birth: September 19, 1952
Place of Birth: Omaha , Nebraska
EDUCATION
College:
University of Iowa
Iowa City, Iowa
B.S.
1970 – 1973
Medical School :
University of Iowa
Iowa City, Iowa
M.D.
1973 – 1977
Internship and Residency:
University of California, Davis
Sacramento, CA
Obstetrics and Gynecology
1977 – 1981
Fellowship:
University of California, Irvine
Orange, CA
Department of Obstetrics and Gynecology
Research Fellow
1981 – 1982
Fellowship:
University of California, Irvine
Orange, CA
Department of Obstetrics and Gynecology
Gynecologic Oncology
1981 – 1984
MEDICAL LICENSURE
California : #A32692
1978
CERTIFICATION
Obstetrics/Gynecology
American Board of Obstetrics and Gynecology
1985
Recertification
1997
American Board of Obstetrics and Gynecology
Gynecologic Oncology
1986
American Board of Obstetrics and Gynecology (Fellow)
1987
American College of Surgeons (Fellow)
1987
PROFESSIONAL BACKGROUND
Department of Obstetrics and Gynecology
University of California, Los Angeles
Associate Clinical Professor
1990 – present
Department of Obstetrics and Gynecology
Harbor/UCLA Medical Center
Clinical Associate Professor
1989 – 1998
Department of Obstetrics and Gynecology
University of Nevada
Clinical Associate Professor
1985 – 1989
Department of Obstetrics and Gynecology
Division of Gynecologic Oncology
University of California Irvine
Assistant Professor
1984 – 1988
Department of Obstetrics and Gynecology
Division Gynecologic Oncology
University of California Irvine
Clinical Instructor
1981 – 1984
PROFESSIONAL SOCIETIES
American College of Obstetrics and Gynecology
American College of Surgeons
Orange County Obstetrics and Gynecology Society
Western Association of Gynecologic Oncologists
Society of Gynecologic Oncologists
American Society of Clinical Oncology
Orange County Medical Association
American Association of Gynecologic Laparoscopists
Orange County Foundation for Medical Care
American Career College, Program Advisory Committee
AWARDS
American Cancer Society
Junior Faculty Clinical Fellow
1985-1986
American Cancer Society
Junior Faculty Clinical Fellow
1984-1985
Excellence in Teaching Award
University of California Irvine
Department of Obstetrics and Gynecology
1984
American Cancer Society
Regular Clinical Fellow
1983-1984
Excellence in Teaching
University of California, Los Angeles
David Geffen School of Medicine
Department of Obstetrics and Gynecology
2010
CalOptima Circle of Life Award
2011
Grants:
American Cancer Society – Cancer Research Institute
Phototherapy of Intraepithelial Neoplasia
1982
Cancer Research Coordinating Committee
University of California Irvine
Phototherapy of Malignant and Premalignant Gynecologic Lesions
1983
National Cancer Institute
Division of Cancer Research
Photoradiation Therapy of Induced Dysplasia in Mice #r01 ca 33753-01
1983-6
Resource Allocation Advisory Committee
University of California , Irvine
Continuous Pelvic Arterial Infusion with Mitomycin-c for Squamous
Carcinoma of the Cervix Recurrent to the Pelvis after Radiation Therapy
1984
Ayerst Laboratories
Subjective Evaluation of the Efficacy of Phasic Premarin compared with
Fixed Dose Premarin in the Treatment of Vasomotor Symptoms of the
Natural Menopause (high dose regimen)
1986
Burroughs-Wellcome Laboratories
Randomized Comparison of Subcutaneous Interferon and Topical
Podophyllin Therapy for Treatment of Genital Condyloma
1986
Ribi Biochemical
Treatment of Advanced Ovarian Carcinoma with Intraperitoneal Ovamid
1986
Ribi Biochemical
Treatment of Genital Condylomata with Detox
1986
Oclassen Pharmaceuticals
Condylox Therapy of Patients with Condyloma Acuminata
1989
Bristol Myers
Three Hour Taxol/Carboplatinum First Line Treatment of Patients with Stage III/IV Ovarian Adenocarcinoma
1993
One Hour Taxol/Carboplatinum First Line Treatment of Patients with Stage III/IV Ovarian Adenocarcinoma
1995
Amgen
Carboplatinum/Cytoxan/Neupogen First Line Treatment of Patients with Stage III/IV Ovarian Adenocarcinoma
1992
Smith Kline Beecham
Three Day Topotecan
Second Line Treatment of Patients with Recurrent Ovarian Adenocarcinoma
1997
Eli Lilly
Gemzar/Taxol/Carboplatinum First Line Treatment of Patients with Stage III/IV Ovarian Adenocarcinoma
1997
Altarex
Treatment of Recurrent Ovarian Cancer with Ovarex
1999
POST-GRADUATE COURSES PRESENTED
Office Gynecology Update
Long Beach , California
1984
Techno-Gynecology
Irvine , California
1986
Office Gynecology Update
Long Beach , California
1987, 1988, 1989, 1990
Colposcopy for the Family Practitioner
Anaheim , California
1990
Advances in Health Care for Women Over 40
New Orleans , Louisianna
1995
PRESENTATIONS
Photoradiation Therapy of Gynecologic Tumors.
Gynecologic Oncology Group Annual Clinical Meeting
Colorado Springs , Colorado
1983
Phase I IP Cisplatin/Cytarabine.
Second International Conference on Intracavitary Chemotherapy
San Diego , California
1988
Phase II Cytarabine/Bleomycin/Cisplatin as Salvage.
Second International Conference on Intracavitary Chemotherapy
San Diego , California
1988
PUBLICATIONS
1. Rettenmaier , MA ; Hanson, F: A comparison of Intravaginal Prostaglandin e2 and Intra-Amniotic f2-alpha in second trimester abortion. Surg Gynecol Obstet 156:585-588, 1982
2. Stratton, JA; Braly, PS; Rettenmaier , MA ; DiSaia, PJ:Depressed natural killer cell activity in tumor bearing rats: Effect of immunotherapy and cytoreductive chemotherapy. Clin Immunol Immunopathol 28:170-176, 1983
3. Stratton, JA; Rettenmaier, MA; Berman, ML; DiSaia, PJ: The response of gynecologic tumors to chemotherapy: Correlation of the chemosensitivity predicted by the subrenal capsule implant assay with the clinical response of the patients.Thirteenth International Congress of Chemotherapy (ed. KH Spitzy and K. Karrer) 11:123-126, 1983
4. Rettenmaier, MA; Ray, DA; Stospkopf, CG, DiSaia, PJ; Berman, ML: The use of gallium scanning and HCG determination to follow resorption of an abdominal placenta.Am J Obstet Gynecol 146:471-473, 1983
5. Stratton, JA; Rettenmaier , MA ; Braly, PS; DiSaia, PJ:Accurate prediction of tumor growth in vivo: The subrenal capsule implant site.J Bio Response Mod 2:272-279, 1983
6. Stratton, JA; Rettenmaier , MA ; DiSaia, PJ:In vivo antineoplastic activity of various biologic response modifiers: Adenocarcinoma of the ovary and breast. J Clin Lab Immunol 11:181-187, 1983
7. Berns, MW; Rettenmaier , MA ; McCullough, J; Wilie, A; Berman, M; DiSaia, PJ; Weinstein, G: Response of psoriasis to red laser light (630) following systemic injection of hematoporphyrin derivative. Lasers in Surg Med 4:73, 1983
8. McCullough, JL; Weinstein, GD; Rettenmaier , MA ; Berns, MW:Cutaneous photosensitization by topical hematoporphyrin derivative formulations: Potential clinical applications. Proc ICLEO International Meeting, 1983
9. Rettenmaier, MA; Berman, ML; DiSaia, PJ; Burns, RG; Berns, MW:Photoradiation therapy of gynecologic malignancies.Gynecol Oncol 17:200-206, 1984
10. Rettenmaier, MA; Berman, ML; DiSaia, PJ; Burns, RG; Weinstein, GD; McCullough, JL; Berns, MW: Gynecological uses of photoradiation therapy, porphyrin localization and treatment of tumors.Prog Clin Bio Res 170:767, 1984
11. Rettenmaier , MA ; Haesslein, HC:The relationship of maternal weight status to selected pregnancy events.Gynecol Obstet Invest 17:183-189, 1984
12. Rettenmaier, MA; Moore, EA; Berman, ML; Stratton, JA; DiSaia, PJ:A murine model of squamous intraepithelial neoplasia.J Clin Lab Imunol 14:151-154, 1984
13. Rettenmaier, MA; Crade, M; Isterm, PD; DiSaia, PJ; Berman, ML:Drainage of a mucometra under real-time ultrasound guidance.J Clin Ultrasound 12:423-424, 1984
14. Stratton, JA; Micha, JP; Rettenmaier , MA ; Braly, PS; DiSaia, PJ:Chemosensitivity testing of non-solid tumors by the subrenal capsule implant assay.Gynecol Oncol 17:185-188, 1984
15. Rettenmaier , MA ; Miller, RD; Berman, ML; DiSaia, PJ:A pharmacokinetic study of moxalactam in patients undergoing gynecologic surgery.Am J. Obstet Gynecol 150:882, 1984
16. Stratton, JA; Kucera, PR; Micha, JP; Rettenmaier, MA; Braly, PS;Berman, ML; DiSaia, PJ: The subrenal capsule tumor implant assay as a predictor of clinical response to chemotherapy: Three years experience.Gynecol Oncol 19:336, 1984
17. Rettenmaier, MA; Senyei, AE; Widder, KJ; Stratton, JA; DiSaia, PJ:In vivo alteration of res phagocytosis by albumin microspheres.J Clin Lab Immunol 17:99, 1985
18. Weckstein, LN; Boucher , AR ; Rettenmaier , MA :Accurate diagnosis of early ectopic pregnancy.Obstet Gynecol 65:393-397, 1985
19. Rettenmaier , MA ; Braly, PS; Roberts, WS; Berman, ML; DiSaia, PJ:Treatment of cutaneous vulvar lesions with skinning vulvectomyJ Repro Med 30:478, 1985
20. Briggs, GG; Berman, ML; Lange, S; Riker, J; Rettenmaier, MA; DiSaia, PJ:Morphine: Continuous intravenous infusion versus intramuscular injections for postoperative pain relief.Gynecol Oncol 22:288, 1985
21.York, AC; Rettenmaier , MA :An unusual complication of delayed treatment of fetal demise.Am J Obstet Gynecol 150:101, 1985
22. Rettenmaier, MA; Micha, JP; Kucera, PR; Berman, ML; DiSaia, PJ:A simplified method of right atrial catheter insertion.Gynecol Oncol 21:207, 1985
23. Micha, JP; Kucera, PR; Preve, CV; Rettenmaier, MA; Braly, PS; Berman, ML; DiSaia, PJ: Action of 2-beta-d-ribofurano sylthiazole-4-carboxamide (tiazofuran) against untreated human ovarian cancers in the murine xenograft assay.Gynecol Oncol 21:351, 1985
24. Rettenmaier, MA; Micha, JP; Braly, PS; Silva, PD; Berman, ML; DiSaia, PJ:A semipermanent right atrial catheter in gynecologic cancer patients.Obstet Gynecol 66:559, 1985
25. Micha, JP; Kucera, PR; Sheets, EE; Rettenmaier, MA; DiSaia, PJ:Prophylactic mezlocillin in patients undergoing radical hysterectomy.Proceedings of the 11th World Congress of Gynecology and Obstetrics.Berlin, FRG., 1985
26. Rettenmaier , MA ; DiSaia, PJ:Early invasive vulvar cancer. 11th World Congress of Gynecology and Obstetrics.Berlin, FRG., 1985.Published in Archives of Gynecology (suppl), 1985
27. Rettenmaier , MA ; Stratton, JS; DiSaia, PJ:Murine xenograft chemosensitivity assay, 11th World Congress of Gynecology and Obstetrics. Berlin , FRG., 1985 Published in Archives of Gynecology (suppl), 1985
28. Stratton, JA; Kucera, PR; Rettenmaier, MA; Micha, JP; Braly, PS; Berman, ML; DiSaia, PJ: Accurate laboratory predictions of the clinical response of advanced ovarian cancer patients to treatment with cyclophosphamide, doxorubicin and cisplatin.Gynecol Oncol 26:302, 1986
29. Rettenmaier , MA ; Berman, ML; DiSaia, PJ:Treatment of advanced ovarian cancer with polyinosinic-polycytidylic acid (poly ICLC)Gynecol Oncol 24(3):359, 1986
30. Rettenmaier , MA ; Stratton, JA; Berman, ML; Senyei, A; Widder, K; White, DB; DiSaia, PJ: Treatment of a syngeneic rat tumor with magnetically responsive albumin microspheres labelled with doxorubicin or protein A.Gynecol Oncol 27(1):34-43, 1987
31. Rettenmaier , MA ; Berman, ML; DiSaia, PJ:Skinning vulvectomy for the treatment of multifocal vulvar intraepithelial neoplasia: A re-appraisal.Obstet Gynecol 69(2):247, 1987
32. Stratton, JA; Rettenmaier, MA; Kucera, PR; Berman, ML; DiSaia, PJ:Concordance of combination and single agent chemosensitivity prediction ovarian carcinoma using the subrenal capsule xenograft assay (SRCA).Gynecol Oncol 30:416-421, 1988
33. Kucera, PR; Berman, ML; Sheets, EE; Micha, JP; Rettenmaier, MA; Treadwell, P; DiSaia, PJ: Whole abdominal radiotherapy for patients with minimal residual epithelial ovarian cancer.Gynecol Oncol 361(3):338-342, 1990
34. Homesley, HD; Blessing, JA; Rettenmaier, MA; Capizzi, RL; Major, FJ; Twiggs, LF:Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Obstet Gynecol 72:413-418, 1988
35. Rettenmaier, MA; Moran, MF; Ramsinghani, NF; Colman M; Syed NA; PuthawalaA; Jansen FW; DiSaia, PJ: Treatment of advanced and recurrent squamous carcinoma of the uterine cervix with constant intra-arterial infusion of cisplatin.Cancer 61:1301-1303, 1988
36. Slayton RE; Blessing JA; Rettenmaier MA; Ball H:A phase II trial of diaziquone (AZQ) in the treatment of patients with recurrent nonsquamous cell carcinoma of the cervix. (A Gynecologic Oncology Group Study) Inv New Drugs 7(4):Nov 1989
37. Stratton JA; Rettenmaier MA; Phillips HV; Herabutya S; DiSaia PJ:Relationship of serum CA-125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.Obstet Gynecol 71(1):20-26, 1988
38. Homesley HD; Blessing JA; Schlaerth J; Rettenmaier MA; Major F:Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. A Gynecologic Oncology Group Study.Gynecol Oncol 39:305-308, 1990
39. Mannel RS; Stratton JA; Rettenmaier MA; Liao SY; DiSaia PJ:Use of a murine for comparison of intravenous and intraperitoneal cisplatin in the treatment of microscopic ovarian cancer.Gynecol Oncol 31:50-55, 1988
40. Rettenmaier MA; Casanova D; Micha JP; Moran M; Ramsanghani N; Syed N; Puthawala A; DiSaia PJ: Radical hysterectomy and tailored postoperative radiation therapy for bulky stage 1B cervical cancer.Cancer 63:2220-2223, 1989
41:Mannel RS; Stratton JA; Moran G; Rettenmaier MA; Liao S; DiSaia PJ: Intraperitoneal cisplatin: Comparison of antitumor activity and toxicity as a function of saline concentration in the solvent.Gynecol Oncol 34(1):50-53, 1989
42: Stratton JA; Mannel RS; Rettenmaier MA; Berman ML; DiSaia PJ:Treatment of advanced and recurrent endometrial carcinoma: Correlation of patient response to hormonal and cytotoxic chemotherapy and the response predicted by the subrenal capsule chemosensitivity assay.Gynecol Oncol 32:55-59, 1989
43:Chien RTY; Rettenmaier MA; Micha JP; DiSaia PJ:Ovarian epithelial tumors of low malignant potential.Surg Gynecol Obstet 169:143-146, 1989
44. Peavy GM; Rettenmaier MA; Berns MW:Carbon dioxide laser ablation and doxorubicin treatment of vaginal fibrosacroma in a dog.J Am Veterinary Med Assoc 201(1):109-110, 1992
45. Micha, JP; Rettenmaier, MA; Dillman, R; Fraser, P; Birk, C; Brown, JV: Single Dose Dexamethasone Taxol Premedication. (Gynecol Oncol 69: 122-124, 1998
46. Micha, JP; Rettenmaier , MA ; Francis, L; Willenberg, R; Brown, JV: “Medically Necessary” Panniculectomy to Facilitate Radical Pelvic Surgery in Morbidly Obese Patients. Gynecol Oncol 69:237-242, 1998
47. Brown, JV; Rettenmaier, MA; Dillman, R; Birk, C; Culkin, K; Micha, JP: Three hour paclitaxel infusion and carboplatin is an effective outpatient treatment for stage III epithelial ovarian cancer Gynecol Oncol; 68:166-168, 1998
48. Brown, JV, Peters WA, Rettenmaier MA, Karlan BY, Dillman RO, Smith MR, Drscher CW, Micha JP: A Phase I Trial of a 3-Day topotecan Q 21 Days for Recurrent epithelial Cancers of the Ovary, fallopian Tube, and Peritoneum. Gynecol Oncol 79:495-498, 2000
49. Brown JV, Peters WA, Rettenmaier MA, Graham CL, Smith MR, Drescher CW, Micha JP: Three Consecutive Day Topotecan is an Active Regimen for Recurrent Epithelial Ovarian Cancer. Gynecol Oncol 88 136-140, 2003
50. Rettenmaier M, Brown J, Micha M: Modified vestibulectomy is inadequate treatment for secondary vulvar vestibulitis. J Gynecol Surg 19(1):13-18, 2003
51. Micha JP, Goldstein BH, Hunter JV, Rettenmaier MA, Brown JV: Long-term survival in an ovarian cancer patient with brain metastases. Gynecol Oncol 92:978-980, 2004
52. Rettenmaier MA, Micha JP, Brown JV, Goldstein B: Impact of Gynecologic Oncologists on Referral Patterns and Care of Patients with Uterine Malignancies at a Community Hospital . J Gynecol Surg 20(2):57-63, 2004
53.Pilot Study of Outpatient Paclitaxel, Carboplatin and Gemcitabine for Advanced Stage Epithelial Ovarian, Peritoneal, and Fallopian Tube Cancer. Dr. John P. Micha, Bram H Goldstein, PhD; Mark A Rettenmaier, MD; Julie A Mattison, RN; Cheri Graham, RN;Connie L Birk, RN; John V Brown, MD Gynecol Oncol 94:719-724, 2004
54. Brown JV, Goldstein BH, Rettenmaier MA, Aylward MM, Graham CL, Micha JP. Laser ablation of surgical margins following excisional partial vulvectomy for vulvar intraepithelial neoplasia may decrease recurrences. J Reprod Med 50(5):345, 2005
55. Micha JP, Goldstein BH, Rettenmaier MA, Brown JV. Cecal transposition following total pelvic exenteration. Gynecol Oncol 94:589-92, 2004
56. John P. Micha, Bram H Goldstein, Philip A Robinson, Mark A Rettenmaier, John V Brown. Abdominal/Pelvic Coccidioidomycosis. Gynecol Oncol 96(1):256-258, 2005
57. John P. Micha, Bram H Goldstein, Julie A Mattison, Kathy M Bader, Cheri Graham, Mark A Rettenmaier, John V Brown, Maurie Markman. Experience with single agent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel and gemcitabine in advanced ovarian cancer. Gynecol Oncol 96(1):132-135, 2005
58. Brown JV, Goldstein BH, Duma CM, Rettenmaier MA, Micha JP. Gamma-Knife radiosurgery for the treatment of ovarian cancer metastatic to the brain. Gynecol Oncol 97:858-61, 200559. Micha JP, Goldstein BH, Bock BV, Rettenmaier MA, Brown JV. Spontaneous bacterial peritonitis. Int J Gynecol Surg 16:908-911, 2006
60. Micha JP, Goldstein BH, Rettenmaier MA, Brown JV, Markman M. Surgery alone or surgery with a combination of radiation or chemo-radiation for management of patients with bulky stage 1b2 cervical carcinoma. Int J Gynecol Cancer 2006; 16: 1-5
61. Micha JP, Goldstein BH, Rettenmaier MA, Brown JV. A rare case of coccygeal endometriosis. Obstet Gynecol 107(2):1, 2006
62. Rettenmaier MA, Goldstein BH, Brown JV, Micha JP. Recurrent gestational trophoblastic disease following persistently normal hCG titers: A rare occurence. Am J Clin Oncol 30(1) 1, 2007
63. Rettenmaier MA, Goldstein BH, Stallman JM, Brown JV, Micha JP. Greatly elevated serum ca-125 level in a patient with a ruptured endometrioma. J Gynecol Surg 2005; 21: 109-112.
64. Brown JV 3rd, Goldstein BH, Rettenmaier MA, Aylward MM, Graham CL, Micha JP.Laser Ablation of Surgical Margins After Excisional Partial Vulvectomy for VIN.Obstet Gynecol Surv 2005;60:584-5
65. Micha JP, Goldstein BH, Birk CL, Rettenmaier MA, Brown JV. Abraxane in the treatment of ovarian cancer: The abscence of hypersensitivity reactions. Gynecol Oncol 100:437-438, 2006
66. Rettenmaier MA, Goldstein BH, Stallman JM, Brown JV, Micha JP: Lymphoepithelial carcinoma of the cervix: Review and treatment course. J Gynecol Surg 21:(4)185-188, 2005
66. Rettenmaier MA, Goldstein BH, Epstein HD, Brown JV, Micha JP: Serous psammocarcinoma of the ovary: An unusual finding. Gynecol Oncol 99:(2)510-511, 2005.
67. Fiorentino RP, Zepeda MA, Goldstein BH, John CR, Rettenmaier MA. Pilot Study Assessing Robotic Laparoscopic Hysterectomy and Patient Outcomes. JMIG 2006: 13:60-63
68. Micha, JP, Goldstein BH, Birk CL, Rettenmaier MA, Brown III JV. Abraxane in the
Treatment of Ovarian Cancer: The Absence of Hypersensitivity Reactions. Gynecol Oncol 2006; 100: 437-438
69. Rettenmaier MA, Goldstein BH, Brown JV, Micha JP. Serous Endometrial Intraepithelial Carcinoma: Diagnosis and Clinical Management. J Gynecol Surg 22:73-75,2006
70. Micha JP, Goldstein BH, Rettenmaier MA, Brown JV. Neovagina reconstruction utilizing bladder and urethra following radical radiation therapy. J Gynecol Surg 2006; 22:73-75
71. Micha JP, Goldstein BH, Rettenmaier MA, Caillouette JT, Fee MJ, Brown JV. Pelvic radiation necrosis and osteomyelitis following chemoradiation fo advanced stage vulvar and cervical carcinoma. Gynecol Oncol 2006;101: 349-352
72.Micha JP, Goldstein BH, Epstein HD, Rettenmaier MA, Brown JV. Ovarian cancer metastatic to the breast. Gynecol Oncol 2006; 102:386-390
73.Rettenmaier MA, Goldstein BH, Micha JP, Brown JV. Vaginal reconstruction following supralevator total pelvic exenteration. Gynecol Oncol 2006; 102:397-399
74. Micha JP, Goldstein BH, Rettenmaier MA, Oglevie S, Lindsay SF, Haskell R, Brown JV.
Subclavian artery puncture repair with Angio-Seal deployment. Gynecol Oncol 2007 ; 104: 761-3
75. Brown JV, Goldstein B, Lopez K, Rettenmaier MA, Graham C, Micha P. A phase II multi-center trial of weekly topotecan in patients with recurrent platinum sensitive epithelial cancers of the ovary, fallopian tube, and peritoneum. Int J Gynecol Cancer 2008; 18:249-254
76. Micha JP, Goldstein BH, Zusman D, Rettenmaier MA, Epstein HD, Brown JV. Malignant pericardial. effusion secondary to ovarian adenocarcinoma. JRM 52:971-973, 2007
77. Micha JP, Goldstein BH, Rettenmaier MA, Brown JV. A Precarious Case of Multiple Enlarged Arteriovenous Malformations in the Uterus. J Gynecol Surg 2007; 23: 220-4
78.Micha JP, Goldstein BH, Graham C, Rettenmaier MA, Brown JV, Markman M. Improved survival with single-angent Taxol consolidation/maintenance therapy in advanced ovarian carcinoma. Oncol 2006;71:49-53
79. Micha JP, Goldstein BH, Brown JV, Birk C, Van Horn D, Rettenmaier MA. Tuberculosis mimicking cervical carcinoma. Accepted to Euro J Gynecol Oncol 2007.
80. Micha JP, Goldstein BH, Rettenmaier MA, Genesen M, Graham CL, Bader K,Lopez KL, Nickle M, Brown JV. A Phase II Study of Outpatient First Line Paclitaxel,Carboplatin and Bevacizumab for Advanced Stage Epithelial Ovarian, Peritoneal, andFallopian Tube Cancer. Intl J Gynecol Cancer 2007;17: 1-6.
81. Micha JP, Goldstein BH, Rettenmaier MA, Tinnerman-Minailo E, Brown JV, McCllellan S, Bock BV. Recurrent Vulvar Lymphangitis Cured with Vulvectomy in a Cervical Carcinoma Patient. Accepted to J Reprod Med 2007
82.Micha JP, Goldstein BH, Ellison D, Brown JV, Rettenmaier MA. Low-Grade Pelvic Masses with Spindle Cell and Fibroblastic Proliferation: Case Report. J Med Case Rep 2007;1:16
83.McClellan SN, Hamilton B, Rettenmaier MA, Goldstein BH, Lopez K, John CR. Individual Physician Experience with Laparoscopic Supracervical Hysterectomy in a Single Outpatient Setting. Surg Inn 14(2) June 2007
84. Micha JP, Goldstein BH, Clark M, . Hu JC, Brown JV. Rettenmaier MA Successful Management of Acute Renal Failure with Vaginal Pessary: A Case Report. Gynecol Surg 2008; 5: 49-51.
85.Micha JP, Rettenmaier MA, Kistler M, Epstein HD, Lim J, Brown JV, Goldstein BH . Retroperitoneal Schwannoma Presenting as a Gynecologic Mass: A Rare Case Report. J Gynecol Surg 2007; 23: 157-162.
86. Brown JV, Epstein HD, Kim R, Micha JP, Rettenmaier MA, Mattison JA, Goldstein BH. Rapid Manifestation of CNS Metastatic disease in a Cervical Carcinoma Patient: A Case Report. Oncology 2007;73:273-276
87. Rettenmaier MA, Brown III JV, Micha JP, Heineman FS, Goldstein BH. Marlex Mesh Mimicking an Adnexal Malignancy. Hernia 2009; 13:221-223
88. Goldstein BH, Birk CL, Van Houten M, Veve R, Brown JV, Rettenmaier MA, Micha, JP. Ovarian cancer and late onset paraneoplastic cerebellar degeneration. Arch Gynecol Obstet 2009;280:99-101.
89. Micha JP, Graham CL, Rettenmaier MA, Brown JV, Goldstein BH. .Innovative Clinical Research: The Women’s Cancer Research Foundation Experience. Perspect Health Inf Manag 2009; 6: 1-12
90. Rettenmaier MA, Lopez K, Graham CL, Brown JV, John CR, Micha JP, Goldstein BH. RealHand High Dexterity Instruments for the Treatment of Stage 1 Uterine Malignancy. J Soc Laparoendoscopic Surg 2009; 13:27-31
91. Hamilton B, McClellan SN, Rettenmaier MA, Goldstein BH.Laparoscopic supracervical hysterectomy for benign gynecologic conditions. J Soc Laparoendoscopic Surg 2009; 13:19-21.
92. Rettenmaier MA, Zekry N, Chang M, Palmer A, Brown JV, Micha JP, Goldstein BH. A Heavily Pigmented Vaginal Perivascular Epithelioid Neoplasm. J Obstet Gynaecol 2009; 29: 676 – 677.
93. Rettenmaier MA, Lopez, K, Abaid LN, Brown JV, Micha JP, Goldstein BH. Borderline Ovarian Tumors and Extended Patient Follow-UP: An Individual Institutions’s Experience. J Surg Oncol 2009; 101:18-21.
94. Rettenmaier MA, Abaid LN, Erwin MR, John CR, Micha JP, Brown JV, Goldstein BH. A Retrospective Review of the GelPort System in Single-Port Access Pelvic Surgery. J Min Invasive Gynecol 2009; 16:743-7.
95. Zeckry N, Rettenmaier MA, Abaid LN, John CR, Micha JP, Brown JP,Goldstein BH. Perivascular Epithelioid Cell Neoplasms: A Systematic Review of Prognostic Factors. J Minim Invasive Gynecol 2009; 16:527-32.
96. Rettenmaier MA, Abaid LN, Brown JV, Micha JP, Goldstein BH. Chemotherapy and patient co-morbidity in ventral site hernia development. J Gynecolo Oncol 2009; 20:246-50.
97. Brown JV, Tinnerman-Minailo EJ, Rettenmaier MA, Micha JP, Goldstein BH. The Minailo Knot: a time-saving and cost-saving technique. J Robotic Surg 2010 Jan
98. John V. Brown JV, Micha JP, Rettenmaier MA , Abaid LN, Lopez KL, Goldstein BH. A Pilot Study Evaluating a Novel Regimen Comprised of Carboplatin, Paclitaxel, and Bevacizumab for Advanced Stage Ovarian Carcinoma. Int J Gynecol Cancer 2010; 20: 1132-1136
99. Abaid LN, Goldstein BH, Micha JP, Rettenmaier MA, Brown JV, Markman M. Improved Overall Survival with 12 Cycles of Single-Agent Paclitaxel Maintenance Therapy following a Complete Response to Induction Chemotherapy in Advanced Ovarian Carcinoma. Oncology 2010;78:389-393
100. Rettenmaier MA, Epstein HD, Abaid LN, Bechtol KA, Goldstein BH. Leiomyosarcoma with Synchronous Clear Cell Carcinoma. Onkologie 2010,33(12):695-697. Epub 2010 Nov 26M
101. Abaid LN, Goldstein BH, Lopez KL, Micha JP, Brown JV, Rettenmaier MA, Markman M. The Prognostic Significance of Optimal Debulking in the Setting of a Complete Clinical Response for Advanced Ovarian Carcinoma Patients Receiving Maintenance Chemotherapy. Arch Gynecol Obstet 2011; 283: 1127-1131.
102. Micha JP, Goldstein BH, Rettenmaier MA, Brown JV, John CR, Markman M. The Clinical Utility of CA-125 for Maintenance Therapy in the Treatment of Advanced Stage Ovarian Carcinoma. Int J Gynecol Cancer 2009; 19: 239-241.
103. Brown III JV, Epstein HD, Mattison JN, Micha JP, Rettenmaier MA, Goldstein BH. Occult Fallopian Tube Cancer in a BRCA-1 Breast Cancer Patient: A Case Report. J Minim Invasive Gynecol 2008; 15; 749-51.
104. Lawrence GC, Rettenmaier MA, Heinemann S, Chang M, Goldstein BH. A Precarious Pregnancy involving a Patient with a Large Placental Chorioangioma. Arch Obstet Gynecol 2008; 278:383-6.
105. Micha JP, Brown JV, Sheffer EC, Chan K, Rettenmaier MA, Goldstein BH. Sarcoidosis Imitating Metastatic Cervical Cancer. Arch Gynecol Obstet 2008;277: 441-3.
106. Mendivil A, Rettenmaier MA, Cox C, Abaid LA, Brown JV, Micha JP, Lopez KL, Goldstein BH. Acute and Delayed Complications from Surgery and Adjuvant Radiotherapy in the Treatment of High Risk Endometrial and Cervical Cancer. 2011 Oncology, 81:79-83.
107. Mendivil AA, Abaid LN, Epstein HD, Rettenmaier MA, Brown JV III, Micha JP, Wabe MA, Goldstein BH. Paget’s Disease of the Vulva: A Clinicopathologic Institutional Review. Int J Clin Oncol 2011, manuscript accepted for publication.
108. Abaid LN, Rettenmaier MA, Brown III JV, Micha JP, Mendivil AA, Wabe MA, Goldstein BH. Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancer. J Gynecol Oncol 2012; 23: 22-27.
NON PEER REVIEW PUBLICATIONS
1: Rettenmaier MA:Diagnosis of ectopic pregnancy.Ob/Gyn Clini-Pearls 5:3-4, 1984
2: Rettenmaier MA; Kakkis JA:Endometrial cancer.Ob/Gyn Clini-Pearls 6:5, 1984
3: Rettenmaier MA; Kucera PR:Colorectal cancer screening: Role of the Gynecologist.Contemp Ob/Gyn August, 1985
4: Rettenmaier MA:The murine subrenal capsule assay.Gynecologic Oncology Newsletter.University of California Irvine, Medical Center 6(2), 1985
5: Rettenmaier MA:Early invasive vulvar cancer.Gynecologic Oncology Newsletter.University of California Irvine, Medical Center 6(2), 1985
6: Rettenmaier MA; DiSaia PJ:Radical hysterectomy for carcinoma of the cervix.Ob/Gyn Illustrated. April, 1986
7: Rettenmaier MA:Early invasive vulvar cancer.Cancer Surveillance Project of Orange County (CSPOC)Scanner 2:4, 1986
8: Rettenmaier MA:The murine subrenal capsule assay.Cancer Surveillance Project of Orange County (CSPOC)Scanner 2:8, 1986
9: Rettenmaier MA; DiSaia PJ:Understanding current vaginectomy techniques.Contemp Ob/Gyn 30/(2):109-117, 1987
10: Rettenmaier MA: Vulvar Intraepithelial Neoplasia III: Occult cancer and the impact of margin status on recurrence – Letter to the Editor. Obstet Gynecol 93(4), 1999
11. Micha JP, Goldstein BH, Rettenmaier MA, Brown III JV. A response to Batt: A Rare Case of Precoccygeal Endometriosis .Obstet Gynecol 2006; 108:213-214.
BOOK CHAPTERS
1: Rettenmaier MA; DiSaia PJ:Vulvar disease and vulvectomy(in) Current Therapy in Surgical Gynecology.(ed. C. Garcia; JJ Mikuto; NG Rosenblum) BC Decker, Inc. Philadelphia , 1987
2: Berns MW; Rettenmaier MA; McCullough J; Coffey J; Wile A; Berman ML;DiSaia PJ; Weinstein G:Response of psoriasis to red laser light (630nm) following systemic injection of hematoporphyrin derative.(in) Hematoporphyrin Derivative Photoradiation Therapy of Cancer. pgs. 73-77Alan R. Liss, Inc. New York , 1985(also published as) Lasers in Surgery and Medicine 4:73-77, 1984
3: Rettenmaier MA; Berman ML; DiSaia PJ; Burns RG; Weinstein GD; McCullough JL; Berns MW: Gynecologic uses of photoradiation therapy.(in) Porphyrin Localization and Treatment of Tumors.(ed. DR Doiron; CJ Gomer) Alan R. Liss, Inc. New York , 1984
4: Rettenmaier MA; Stratton JA; DiSaia PJ:The Murine Subrenal Capsule Assay(in) Gynecology and Obstetrics.(ed. H Ludwig; K Thomsen) Springer-Verlag. Berlin , FRG., 1986
5: Rettenmaier MA; DiSaia PJ:Early Invasive Vulvar Cancer(in) Gynecology and Obstetrics.(ed. H Ludwig; K Thomsen) Springer-Verlag. Berlin , FRG., 1986
6: Rettenmaier MA; DiSaia PJ:Vaginectomy(in) Gynecologic Surgery pg. 151(ed. Luis E. Sanz)Medical Economics Books, New Jersey , 1988
7: Rettenmaier MA:Gynecologic Oncology Update(in) Prolog Gynecology (2nd edition)(ed. Harrison C. Visscher)The American College of Obstetricians and Gynecologists, 1988
ABSTRACTS AND PRESENTATIONS
1: Trelford JD; Rettenmaier MA; Deer DA; and Radiation Oncology Center : Carcinoma of the vulva: A review. Western Association of Gynecologic Oncologists Annual Meeting, Napa , California . 1981
2: Rettenmaier MA; Stratton J; DiSaia PJ: The effect of magnetically responsive albumin microspheres on phagocytic function. Thirteenth International Cancer Congress. Seattle , Washington . 1982
3: Stratton JA; Braly PS; Rettenmaier MA; DiSaia PJ:Predicting chemotherapeutic sensitivity for human ovarian tumors: A comparison of three assays. Thirteenth International Cancer Congress. Seattle , Washington . 1982
4: Rettenmaier MA; Haesslein HC; Niswander KR: The relationship of maternal weight status to selected pregnancy events. EJ Quilligan Symposium San Diego , California . 1982
5: Rettenmaier MA; Stratton JA; Berman ML; DiSaia PJ: Antitumor activity of a polynucleotide interferon inducer in human ovarian cancer. Western Association of Gynecologic Oncologists Annual Meeting, Santa Fe , New Mexico . 1982
6: Stratton JA; Micha JP; Braly PS; Rettenmaier MA; DiSaia PJ: Correlation between chemotherapeutic sensitivity measured by the subrenal capsule tumor implant assay and the clinical response of patients with gynecologic tumors. Thirteenth International Congress of Chemotherapy, Houston , Texas . 1983
7: Rettenmaier MA; Haesslein HC: The relationship of maternal weight status to selected pregnancy risk factors. District Eight and Nine, American College of Obstetrics and GynecologyAnnual Meeting. Vancouver , British Columbia . 1981
8: Micha JP; Stratton JA; Senyei AE; Braly PS; Rettenmaier MA; Berman ML; DiSaia PJ: The effect of tumor burden on tumor growth and response to chemotherapy in immunocompetent mice. Society of Gynecologic Oncologist Annual Meeting. Scottsdale , Arizona . 1983
9: Boucher AR ; Weckstein LN ; Rettenmaier MA: Accurate diagnosis of ectopic pregnancy. District Eight and Nine, American College of Obstetrics and GynecologyAnnual Meeting. Monterey , California . 1983
10: Rettenmaier MA; Miller RD ; Berman ML; Stratton JS; DiSaia PJ: Penetration of moxalactam in patients undergoing gynecologic cancer surgery. Western Association of Gynecologic Oncologists Annual Meeting, Colorado Springs , Colorado . 1983
11: Rettenmaier MA; Berman ML; DiSaia PJ; Burns RG; Berns M: Gynecologic uses of photoradiation therapy. Clayton Foundation Symposium on Porphyrin Localization and Treatment of Tumors. Santa Barbara , California . 1983
12: Stratton JA; Micha JP; Braly PS; Rettenmaier MA; Berman ML; DiSaia PJ: The response of gynecologic tumors to chemotherapy: Correlation of the chemosensitivity predicted by the subrenal capsule implant assay with the clinical responses of the patients. Thirteenth International Congress of Chemotherapy, Houston , Texas . 1983
13: Rettenmaier MA; Braly PS; Roberts WS; Berman ML; DiSaia PJ: Treatment of cutaneous vulvar lesions with skinning vulvectomy. Western Association of Gynecologic Oncologists Annual Meeting, Colorado Springs , Colorado . 1983
14: Micha JP; Rettenmaier MA; DiSaia PJ; Gupta S: Immunologic assessment of ovarian cancer patients treated with interferon. Western Association of Gynecologic Oncologists Annual Meeting, Colorado Springs , Colorado . 1983
15: McCullough JL; Weinstein GD; Rettenmaier MA; Berns MW: Cutaneous photosensitization by topical hematoporphyrin derivative formulations: Potential clinical applications. ICLEO International Meeting, Los Angeles , California . 1983
16: Micha JP; Berman ML; Romansky S; Rettenmaier MA; Flamm MS; Kucera PR; DiSaia PJ: Malignant ovarian germ cell tumors: A review of 17 cases. Society of Gynecologic Oncologists Annual Meeting, Miami , Florida . 1984
17: Rettenmaier MA; Braly PS; Micha JP; Silva PD; Edwards GS; Berman ML; DiSaia PJ: The use of a permanent right atrial catheter in gynecologic cancer patients. Felix Rutledge SocietyAtlanta, Georgia . 1984
18: Briggs GG; Berman ML; Lange S; Bohart R; Riker J; Braly PS; DiSaia PJ; Rettenmaier MA: Comparison of two regimens of postoperative pain control in gynecologic cancer patients. Western Association of Gynecologic Oncologists Annual Meeting, Sun River , Oregon . 1984
19: Rettenmaier MA; Stratton JA; DiSaia PJ; Berman ML; Senyei A; Widder K: Treatment of a syngeneic rat tumor with magnetically responsive albumin microspheres labelled with adriamycin or protein A. Society of Gynecologic Oncologists Annual MeetingMiami , Florida . 1985
20: Kucera PR; Sheets EE; Micha JP; Rettenmaier MA; Berman ML; DiSaia PJ: Whole abdominal radiotherapy for patients with minimal residual epithelialovarian cancer. Western Association of Gynecologic Oncologists Annual MeetingSan Diego , California . 1985
21: Micha JP; Kucera PR; Birkett JP; Rettenmaier MA; Chambers G; Sheets EE;Stoskopf CG; Berman ML; DiSaia PJ: Prophylactic mezlocillin in radical hysterectomy. Western Association of Gynecologic Oncologists Annual MeetingSan Diego , California . 1985
22: Rettenmaier MA; Berman ML; Braly PS; Micha JP; Kucera PR; DiSaia PJ: Skinning vulvectomy for treatment of vulvar intraepithelial neoplasia. Western Association of Gynecologic Oncologists Annual Meeting, San Diego , California . 1985
23: Micha JP; Kucera PR; Sheets EE; Rettenmaier MA; DiSaia PJ: Prophylactic mezlocillin in patients undergoing radical hysterectomy. 11th World Congress of Gynecology and Obstetrics, Berlin , FRG. 1985
24: Stratton JA; Rettenmaier MA; Kucera PR; Berman ML; DiSaia PJ: Concordance of multiple and single agent chemosensitivity prediction in ovarian carcinoma using the subrenal capsule xenograft assay (SRCA). American Association of Cancer Researchers Annual Meeting, Los Angeles , California . 1986
25: McCullough JL; Berns MW; Rettenmaier MA: Photosensitizers in dermatology. American Society for Photobiology, Los Angeles , California . 1986
26: Rettenmaier MA; Casanova DM; Panganiban RL; Berman ML; DiSaia PJ: Radical hysterectomy in the management of bulky stage 1B cervical cancer. The Society of Pelvic Surgeons 36th Annual Meeting, Newport Beach , California . 1986
27: Syed NAM ; DiSaia PJ; Berman ML; Rettenmaier MA; Colman M: The use of open implants in the management of pelvic cancers. The Society of Pelvic Surgeons 36th Annual Meeting, Newport Beach , California . 1986
28: Homesley HD; Blessing JA; Rettenmaier MA; Majors FJ; Twiggs L: Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. The Society of Gynecologic Oncologist Annual Meeting, Miami , Florida . 1987
29: Douglas J; Flowers F; Rettenmaier MA; Britt P; Weck P: Comparison of interferon alfa-N1, podophyllin or combination therapy forrecurrent genital warts. VIIth International Congress of Virology, Ottawa , Ontario , Canada . 1987
30: Mannel RS; Berman ML; Rettenmaier MA; Walker J; Sheets EE; DiSaia PJ: Evaluation of clinical stage II endometrial cancer treated with primary surgical therapy. Western Association of Gynecologic Oncologists Annual Meeting, Tucson , Arizona . 1987
31: Walker J; Wilczynski S; Bergen S; Sheets EE; Rettenmaier MA; Berman M; DiSaia PJ: Is cervical cancer in young women a different disease? Western Association of Gynecologic Oncologists Annual Meeting, Tucson , Arizona . 1987
32: Puthawala AA; Syed AMN; DiSaia PJ; Berman M; Rettenmaier MA: Thermoendocurietherapy for recurrent and/or persistent pelvic tumors. Western Association of Gynecologic Oncologists Annual Meeting, Tucson , Arizona . 1987
33: Douglas J; Eron L; Delgado G; Rettenmaier MA; Flowers F; Britt P; Weck P: A multicenter randomized trial of systemic interferon, podophyllin, or both for recurrent anogenital warts. Sixth Papilloma Virus Workshop (Submitted)
34: Stratton JA; Nguyen BL; Rettenmaier MA; Berman ML; DiSaia PJ: Concordance of CA125 and LSA tumor associated antigen levels and the disease status of patients with gynecological malignancies. American Society of Clinical Oncology 23rd Annual Meeting, Atlanta , Georgia . 1987
35: Mannel RS; Stratton JA; Rettenmaier , MA ; Liao SY; DiSaia PJ: Cis-Dichlorodiammineplatinum(II) comparison of antitumor activity and toxicity as a function of saline concentration in the vehicle of administration. American Association for Cancer Research 78th Annual Meeting, Atlanta , Georgia . 1987
36: Sutton G; Blessing J; McGuire W; Photopulos G; Rettenmaier MA: Phase II trial of ifosfamide in patients with recurrent or advanced mixed mesodermal tumors of the uterus. American Society of Clinical Oncologists Annual Meeting, New Orleans , Louisiana . 1988
37: Mannel RS; Stratton JA; Rettenmaier MA; Liao SY; DiSaia PJ: Use of a murine model for comparison of intravenous and intraperitoneal cisplatin in the treatment of microscopic ovarian cancer. Society of Gynecologic Oncologists Annual, Meeting Miami , Florida . 1988
38: Kreter B; Ozasa D; Rettenmaier MA; Bergen S: Tissue levels of cefonocid obtained during radical hysterectomy. American College of Clinical Pharmacy Meeting, Philadelphia , Pennsylvania . 1988
39: Blessing JA; Schlaerth JB; Rettenmaier MA; Major FJ: Dose intensity study of weekly intramuscular methotrexate (WIM) for nonmetastatic gestational trophoblastic disease (NGTD). American Society of Clinical Oncologists Annual Meeting, San Francisco , California . 1989
40: Bloss JD; Berman ML; Mukhurjee J; Manetta A; Emma D; Rettenmaier MA;DiSaia PJ: Bulky stage 1B cervical carcinoma managed by primary radical hysterectomy followed by tailored radiotherapy. Society of Gynecologic Oncologists Annual Meeting, San Antonio , Texas . 1992
41. Brown JV; Peters WA; Rettenmaier MA; Karlan BY; Dillman RA; Smith MR; Drescher CW; Micha JP: A phase 1 trial of three day topotecan Q 21 days for recurrent epithelial mullerian malignancies. Society of Gynecologic Oncologists Annual Meeting, San Diego , California , 2000
42. Brown JV, Rettenmaier MA, Dillman RA, et al. Three-hour paclitaxel infusion and carboplatin is an effective outpatient treatment for stage III epithelial ovarian cancer. Gynecol Oncol ( United States ), Feb 1998, 68(2) p166-8
43. Brown JV, Peters WA, Rettenmaier MA, Drescher CW, Smith MR, Dillman RA, Micha JP. Three-consecutive-day Topotecan is an active regimen for recurrent epithelial ovarian cancer. Society of Gynecologic Oncologist Annual Meeting, Miami , Florida . 2002
44. Micha JP, Goldstein BH, Rettenmaier MA, Bader K, Graham C, Lopez K, Nickle M, Genesen M, Brown JV III. Pilot Study of Outpatient Paclitaxel, Carboplatin and Bevacizumab for Advanced Stage Epithelial Ovarian, Peritoneal, and Fallopian Tube Cancer. 11 th Annual International Gynecologic Cancer Society Meeting, Annual Meeting ,Santa Monica , CA 2006.
45. Abaid LN, Micha JP, Rettenmaier MA, Brown JV III, Mendivil AA, Lopez KL, Goldstein BH. A phase II study of modified dose-dense paclitaxel and every 4 week carboplatin for the treatment of advanced stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma. Society of Gynecologic Oncology 42nd Annual Meeting, Austin TX, March 24-27, 2012.Back to Top